Lineage Cell Therapeutics Inc (LCTX)

[Cincinnatus]

I'm not sure you understand the significance of them listing the 510(k) clearance on the slide. These device approvals can happen in as little as 90 days. Since the drug involved is already FDA approved, they would need no other approval.

If you read Patrick Cox Tech Digest of 1/29/18, you will get a little more information and hear his enthusiasm. He is nearing 80 and is talking about how fast moving this research is and possible to help him in his lifetime.

One man's opinion, of course, but he has pretty good research credentials, even though he's often WAY, WAY early in his enthusiasms.

When AgeX splits off, it will be interesting what info is released about Renelon at that time. Cox is claiming that verifying data on the FDA approved drug's ability to affect the COX7A1 gene is already available, but BTX is waiting to get the patent trail and commercialization/trade secrets established so it will be difficult/impossible to derail the effort. As soon as they start talking about specific plans to go with the 510(k) route, (big question is "how soon") things should become VERY interesting VERY fast.